Acadian Asset Management LLC Eton Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $35.4 Billion
- Q1 2025
A detailed history of Acadian Asset Management LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 402,428 shares of ETON stock, worth $7.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
402,428
Previous 248,505
61.94%
Holding current value
$7.89 Million
Previous $3.31 Million
57.91%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
13.8MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$55.9 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$38 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$23 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$21.6 Million0.0% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$13.6 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $496M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...